EMVision To Raise $4,500,000 before cost for Product Development

  • Nov 05, 2019 AEDT
  • Team Kalkine

EMVision Medical Devices Limited (ASX: EMV) receives binding commitments from the institutional and sophisticated investors to raise $4,500,000 before cost.

  • EMV intends to utilise the funds in the commercial product development of the Company’s portable brain scanner and to progress clinical validation.
  • The Placement would mark an issue of 6,081,082 new ordinary shares at an issue price of $0.74 per share, which represents a 13 per cent discount to the last traded price of $0.85.
  • The settlement of the Placement is expected to occur on 11 November 2019.


All pictures are copyright to their respective owner(s).Kalkinemedia.com does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.


There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK